Tag

Attr Cm

All articles tagged with #attr cm

health1 year ago•1 min saved

FDA Approves BridgeBio's Heart Drug, Sparking Competition with Pfizer

The FDA has approved BridgeBio's new drug, Attruby, for treating transthyretin amyloid cardiomyopathy (ATTR-CM), marking the first new treatment for this heart condition in over five years. ATTR-CM, which affects over 400,000 people globally, is caused by genetic mutations or aging, leading to amyloid deposits in the heart that impair its function. This approval represents BridgeBio's first major commercial product.

via STAT|

#attr-cm #bridgebio #drug-approval

healthcare2 years ago•0 min saved

BridgeBio's ATTR-CM Trial Demonstrates Significant Mortality and Hospitalization Reduction

BridgeBio has announced positive results from its Phase III trial of acoramidis in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). The trial showed improvements in mortality, cardiovascular-related hospitalizations, a six-minute walk test, and a biomarker of the disease. Patients receiving the drug had an 81% survival rate at 30 months, compared to 74% on placebo, and the drug reduced hospitalization rates by 50%.

via Endpoints News|

#acoramidis #attr-cm #bridgebio